Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | October Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of October.
November 4, 2024
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | October Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of October.
November 4, 2024
Next-Generation Therapeutics
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Roundup 2024
Liquid Biopsy (LBx) continued to develop through September, featuring new strategic collaborations, regulatory and reimbursement developments, and new study results.
October 14, 2024
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Roundup 2024
Liquid Biopsy (LBx) continued to develop through September, featuring new strategic collaborations, regulatory and reimbursement developments, and new study results.
October 14, 2024
Liquid Biopsy
.png)
DeciBio Q&A
Clinical Diagnostics
Advances in Spatial Biology: A Q&A with Aneesh Acharya, CCO at Molecular Instruments
An interview with Aneesh Acharya, CCO of Molecular Instruments, discussing their bioimaging technology using Hybridization Chain Reaction (HCR), its role in spatial biology, and the company's shift towards clinical-grade solutions.
October 10, 2024
DeciBio Q&A
Clinical Diagnostics
Advances in Spatial Biology: A Q&A with Aneesh Acharya, CCO at Molecular Instruments
An interview with Aneesh Acharya, CCO of Molecular Instruments, discussing their bioimaging technology using Hybridization Chain Reaction (HCR), its role in spatial biology, and the company's shift towards clinical-grade solutions.
October 10, 2024
Spatial Biology
.png)
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | September Round-Up
Welcome to our very first newsletter that covers the advances made by AI / ML across drug R&D, diagnostics, and the wider healthcare system.
October 9, 2024
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | September Round-Up
Welcome to our very first newsletter that covers the advances made by AI / ML across drug R&D, diagnostics, and the wider healthcare system.
October 9, 2024
AI / Machine Learning
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - Q3 2024 Update
Q3 2024 saw various developments in the digital health and informatics space.
October 8, 2024
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - Q3 2024 Update
Q3 2024 saw various developments in the digital health and informatics space.
October 8, 2024
Digital Health
Health Technology Market
Women's Health
Medical Devices
DeciBio Q&A
Clinical Diagnostics
Exploring Proteomics: New Approaches to Early Cancer Detection
Ashkan Afshin, Founder of Novelna, shares insights on using proteomics for early cancer detection and offers his perspectives on the early cancer detection and precision medicine landscapes.
October 2, 2024
DeciBio Q&A
Clinical Diagnostics
Exploring Proteomics: New Approaches to Early Cancer Detection
Ashkan Afshin, Founder of Novelna, shares insights on using proteomics for early cancer detection and offers his perspectives on the early cancer detection and precision medicine landscapes.
October 2, 2024
Immuno-Oncology
Proteomics Market
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved